Advanced Health Media, LLC, a Portfolio Company of Arlington Capital Partners, Announces Acquisition of Embryon Group Companies
November 26, 2007 – Advanced Health Media, LLC (“AHM”), the leading U.S. provider of regulatory compliance management systems and related sales logistics services to the pharmaceutical and biotechnology industries, today announced the acquisition of the operations of Embryon Inc., Novus Communications, Inc., Genesis Healthcare, Inc., Centeon Management Group, LLC, and Pharmasource Meeting Services, LLC (collectively, “Embryon”), a privately held provider of salesforce meeting logistics systems and medical communications services to the pharmaceutical industry.
Embryon, based in Somerville, N.J., has 270 employees who provide medical communication and field logistics solutions that help pharmaceutical sales and marketing organizations better interact with their healthcare customers and advisors. Additionally, the Company supplies its customers with specialized management systems that ensure regulatory compliance and automate necessary record-keeping and reporting functions.
The acquisition expands AHM’s product and service offerings, which optimize the interactions of pharmaceutical sales and marketing professionals with healthcare professionals, improve the coordination of marketing activities, and ensure their proactive compliance with relevant regulatory requirements between pharmaceutical companies and healthcare professionals. The acquisition also increases AHM’s scale, resulting in the entity generating over $400 million in revenue.
AHM is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, DC-based private equity firm. “Together, Advanced Health Media and Embryon provide the most sophisticated technology platform in the industry and the acquisition will further cement AHM’s position as the preeminent U.S. provider of regulatory compliance management systems to the pharmaceutical industry,” said Peter Manos, a Partner at Arlington.
John Bates, Principal at Arlington Capital Partners, added, “We believe there will be synergies between AHM and Embryon. Embryon’s loyal customer base presents an attractive opportunity for us to cross-sell to their clients AHM’s wide array of technology and service offerings in the speaker bureau business.”
“With this acquisition, we have expanded our range of offerings that will ultimately enable our pharmaceutical clients to improve their customer relationships,” said Kevin McMurtry, CEO of AHM. “The combination of Advanced Health Media and Embryon will provide the pharmaceutical industry with cross-domain skills in medical communications and logistics that will enable our clients to improve the way they interact with physicians and other healthcare professionals, maintain compliance with regulatory requirements, respond more quickly and tailor their solutions to their customer’s needs.”
In addition to the continued equity support provided by Arlington Capital Partners, debt financing for the transaction was provided by CIT Group, Inc., Deutsche Bank, and The Bank of New York.
About Advanced Health Media, LLC
Advanced Health Media (www.ahmdirect.com) is the leading U.S. provider of meeting logistics, commercial compliance management solutions, and sales force productivity tools for the pharmaceutical industry. AHM has developed and markets a fully-integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, CRM and compliance tracking and reporting systems.
Headquartered in Bridgewater, N.J. and with offices in Union and Somerville, N.J., Philadelphia, PA., and Chesapeake, V.A., Advanced Health Media is also the parent company of Cogenix, LLC, ProMedix, LLC and Insite Research, LLC.
About Arlington Capital Partners
Arlington Capital Partners (www.arlingtoncap.com) is a Washington, DC-based private equity fund with over $1 billion of committed capital focused on middle market buyout investment opportunities in growth industries including: healthcare services, media, business services, education, and aerospace/defense. The firm’s professionals have a unique combination of operating and private equity experience that enables Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field.
SOURCE: Arlington Capital Partners